Gilead Sciences, Inc. (BIT:1GILD)
Italy flag Italy · Delayed Price · Currency is EUR
102.70
-0.94 (-0.91%)
At close: Oct 31, 2025

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.77B USD in the quarter ending September 30, 2025, with 2.97% growth. This brings the company's revenue in the last twelve months to $29.09B, up 2.78% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.

Revenue (ttm)
$29.09B
Revenue Growth
+2.78%
P/S Ratio
5.20
Revenue / Employee
$1.65M
Employees
17,600
Market Cap
128.99B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Recordati Industria Chimica e Farmaceutica2.48B
Amplifon2.41B
DiaSorin1.22B
Safilo Group998.89M
EL.En.579.71M
Svas Biosana134.95M
Pharmanutra122.25M
Philogen84.66M
Revenue Rankings